P.N. Durrington - Concepedia

Author

P.N. Durrington

Manchester Royal Infirmary

Also Known As

Basil Ammori, P N DURRINGTON, P. N. Durrington, P.N. Durrington, PAUL N. DURRINGTON, Paul N. Durrington

Publications

514

Citations

H-Index

Concepts

All Affiliations

Manchester Royal Infirmary University of Manchester Salford Royal Hospital

About

P.N. Durrington is an author at Manchester Royal Infirmary specializing in medicine, obesity, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	125
2	Diabetes	3	3	96
3	Health Sciences	1	1	11
4	Public Health	1	1	18
5	Epidemiology	1	1	18

P.N. Durrington

Publications

218

Citations

H-Index

Page 1

	Year	Citations
Hypertriglyceridemia and hyperuricemia: Effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial M.D. Bastow, P.N. Durrington, M. Ishola Metabolism ObesityMetabolic SyndromeHypertensionThrombosisCardiovascular Disease	1988	67
Effect of Phenobarbitone on Plasma Apolipoprotein B and Plasma High-Density-Lipoprotein Cholesterol in Normal Subjects P.N. Durrington Clinical Science	1979	36
The Prevalence of Hyperlipidaemia and Related Clinical Features in Insulin-dependent Diabetes Mellitus P.N. Durrington, M Ishola, V F Hillier, QJM	1989	34
Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy John H. Brown, Nisar Anwar, Colin D. Short, Nephrology Dialysis Transplantation Heart FailureTransplantation MedicineHyperlipidemiaRenal FunctionChronic Kidney Disease	1993	29
Hypertriglyceridaemia and abnormalities of triglyceride catabolism persisting after pancreatitis P.N. Durrington, O. P. Twentyman, J. M. Braganza, International Journal of Pancreatology	1986	23
Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus Peter Winocour, Lesley Tetlow, P.N. Durrington, Atherosclerosis ObesityMetabolic SyndromeApolipoprotein E PolymorphismDiabetesGenetic Epidemiology	1989	18
The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in Type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia Peter Winocour, P.N. Durrington, Deepak Bhatagnar, Atherosclerosis ObesityType 1Intermediate Density LipoproteinBody CompositionCardiovascular Disease	1992	11

Page 1